Tenn. Code Ann. § 63-2-104
This is the official text of Tenn. Code Ann. § 63-2-104, part of Tennessee’s Code Ann — part of the compiled statutory law of Tennessee, published by the state as "Code Ann." Browse the sections below, each linked to its official government source.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
Electronic medical records - Information blocking prohibited - Procedure for disclosure of test results - Exclusions
Official statutory text
(a) A healthcare professional subject to this title who is considered a business associate, as that term is defined in 45 CFR § 160.103 , shall comply with: (1) The Health Insurance Portability and Accountability Act (HIPAA) ( 42 U.S.C. § 1320d et seq.) and standards for privacy of individually identifiable health information required by 45 CFR Parts 160 and 164; and (2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 . (b) Notwithstanding another law to the contrary, except as provided in subsection (c), a healthcare provider requesting a medical laboratory test for a patient shall not engage in information blocking as described in 42 U.S.C. § 300jj-52 . (c) The following reports, test results, and any other related results must not be disclosed by a designated entity, as defined under § 68-29-103 , to a patient as part of the patient's electronic health record until seventy-two (72) hours after the results are finalized, unless the healthcare provider directs the release of the results before the end of that seventy-two-hour period: (1) Pathology reports or radiology reports that have a reasonable likelihood of showing a finding of new or recurring malignancy; (2) Tests that could reveal genetic markers; (3) A positive HIV test, except that this section does not prevent the disclosure of HIV test results, including viral load and CD4 count test results, to a patient living with HIV by secure internet website or other electronic means if the patient has previously been informed about the results of a positive HIV test pursuant to the requirements of this section; or (4) Presence of antigens indicating a hepatitis infection. (d) This section does not apply to a person or entity that is licensed under this title or title 68. Added by 2024 Tenn. Acts, ch. 931,s 1, eff. 5/6/2024.
(a) A healthcare professional subject to this title who is considered a business associate, as that term is defined in 45 CFR § 160.103 , shall comply with: (1) The Health Insurance Portability and Accountability Act (HIPAA) ( 42 U.S.C. § 1320d et seq.) and standards for privacy of individually identifiable health information required by 45 CFR Parts 160 and 164; and (2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 .
(1) The Health Insurance Portability and Accountability Act (HIPAA) ( 42 U.S.C. § 1320d et seq.) and standards for privacy of individually identifiable health information required by 45 CFR Parts 160 and 164; and
(2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 .
(b) Notwithstanding another law to the contrary, except as provided in subsection (c), a healthcare provider requesting a medical laboratory test for a patient shall not engage in information blocking as described in 42 U.S.C. § 300jj-52 .
ble health information required by 45 CFR Parts 160 and 164; and
(2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 .
(b) Notwithstanding another law to the contrary, except as provided in subsection (c), a healthcare provider requesting a medical laboratory test for a patient shall not engage in information blocking as described in 42 U.S.C. § 300jj-52 .
(c) The following reports, test results, and any other related results must not be disclosed by a designated entity, as defined under § 68-29-103 , to a patient as part of the patient's electronic health record until seventy-two (72) hours after the results are finalized, unless the healthcare provider directs the release of the results before the end of that seventy-two-hour period: (1) Pathology reports or radiology reports that have a reasonable likelihood of showing a finding of new or recurring malignancy; (2) Tests that could reveal genetic markers; (3) A positive HIV test, except that this section does not prevent the disclosure of HIV test results, including viral load and CD4 count test results, to a patient living with HIV by secure internet website or other electronic means if the patient has previously been informed about the results of a positive HIV test pursuant to the requirements of this section; or (4) Presence of antigens indicating a hepatitis infection.
(1) Pathology reports or radiology reports that have a reasonable likelihood of showing a finding of new or recurring malignancy;
(2) Tests that could reveal genetic markers;
(3) A positive HIV test, except that this section does not prevent the disclosure of HIV test results, including viral load and CD4 count test results, to a patient living with HIV by secure internet website or other electronic means if the patient has previously been informed about the results of a positive HIV test pursuant to the requirements of this section; or
(4) Presence of antigens indicating a hepatitis infection.
(d) This section does not apply to a person or entity that is licensed under this title or title 68.
Added by 2024 Tenn. Acts, ch. 931,s 1, eff. 5/6/2024.
(a) A healthcare professional subject to this title who is considered a business associate, as that term is defined in 45 CFR § 160.103 , shall comply with: (1) The Health Insurance Portability and Accountability Act (HIPAA) ( 42 U.S.C. § 1320d et seq.) and standards for privacy of individually identifiable health information required by 45 CFR Parts 160 and 164; and (2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 .
(1) The Health Insurance Portability and Accountability Act (HIPAA) ( 42 U.S.C. § 1320d et seq.) and standards for privacy of individually identifiable health information required by 45 CFR Parts 160 and 164; and
(2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 .
(b) Notwithstanding another law to the contrary, except as provided in subsection (c), a healthcare provider requesting a medical laboratory test for a patient shall not engage in information blocking as described in 42 U.S.C. § 300jj-52 .
ble health information required by 45 CFR Parts 160 and 164; and
(2) Federal laws regulating information blocking, as that term is defined in 45 CFR § 171.103 .
(b) Notwithstanding another law to the contrary, except as provided in subsection (c), a healthcare provider requesting a medical laboratory test for a patient shall not engage in information blocking as described in 42 U.S.C. § 300jj-52 .
(c) The following reports, test results, and any other related results must not be disclosed by a designated entity, as defined under § 68-29-103 , to a patient as part of the patient's electronic health record until seventy-two (72) hours after the results are finalized, unless the healthcare provider directs the release of the results before the end of that seventy-two-hour period: (1) Pathology reports or radiology reports that have a reasonable likelihood of showing a finding of new or recurring malignancy; (2) Tests that could reveal genetic markers; (3) A positive HIV test, except that this section does not prevent the disclosure of HIV test results, including viral load and CD4 count test results, to a patient living with HIV by secure internet website or other electronic means if the patient has previously been informed about the results of a positive HIV test pursuant to the requirements of this section; or (4) Presence of antigens indicating a hepatitis infection.
(1) Pathology reports or radiology reports that have a reasonable likelihood of showing a finding of new or recurring malignancy;
(2) Tests that could reveal genetic markers;
(3) A positive HIV test, except that this section does not prevent the disclosure of HIV test results, including viral load and CD4 count test results, to a patient living with HIV by secure internet website or other electronic means if the patient has previously been informed about the results of a positive HIV test pursuant to the requirements of this section; or
(4) Presence of antigens indicating a hepatitis infection.
(d) This section does not apply to a person or entity that is licensed under this title or title 68.
Added by 2024 Tenn. Acts, ch. 931,s 1, eff. 5/6/2024.
Status: in_force
Need a lawyer in Tennessee?
Find a Tennessee lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.